1. Home
  2. ALUR vs PRPH Comparison

ALUR vs PRPH Comparison

Compare ALUR & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • PRPH
  • Stock Information
  • Founded
  • ALUR 2009
  • PRPH 1989
  • Country
  • ALUR United States
  • PRPH United States
  • Employees
  • ALUR N/A
  • PRPH N/A
  • Industry
  • ALUR
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALUR
  • PRPH Health Care
  • Exchange
  • ALUR Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • ALUR 16.8M
  • PRPH 14.5M
  • IPO Year
  • ALUR N/A
  • PRPH 1997
  • Fundamental
  • Price
  • ALUR $2.14
  • PRPH $0.43
  • Analyst Decision
  • ALUR Strong Buy
  • PRPH
  • Analyst Count
  • ALUR 3
  • PRPH 0
  • Target Price
  • ALUR $22.83
  • PRPH N/A
  • AVG Volume (30 Days)
  • ALUR 52.4K
  • PRPH 2.7M
  • Earning Date
  • ALUR 11-12-2025
  • PRPH 11-12-2025
  • Dividend Yield
  • ALUR N/A
  • PRPH N/A
  • EPS Growth
  • ALUR N/A
  • PRPH N/A
  • EPS
  • ALUR N/A
  • PRPH N/A
  • Revenue
  • ALUR $19,917,000.00
  • PRPH $5,588,000.00
  • Revenue This Year
  • ALUR N/A
  • PRPH $221.82
  • Revenue Next Year
  • ALUR $168.27
  • PRPH N/A
  • P/E Ratio
  • ALUR N/A
  • PRPH N/A
  • Revenue Growth
  • ALUR N/A
  • PRPH N/A
  • 52 Week Low
  • ALUR $1.98
  • PRPH $0.22
  • 52 Week High
  • ALUR $20.00
  • PRPH $2.94
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 40.16
  • PRPH 56.20
  • Support Level
  • ALUR $2.10
  • PRPH $0.34
  • Resistance Level
  • ALUR $2.22
  • PRPH $0.57
  • Average True Range (ATR)
  • ALUR 0.11
  • PRPH 0.06
  • MACD
  • ALUR 0.02
  • PRPH 0.02
  • Stochastic Oscillator
  • ALUR 40.74
  • PRPH 43.12

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: